These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30464186)

  • 21. Early-Life Antibiotic Exposure Associated With Varicella Occurrence and Breakthrough Infections: Evidence From Nationwide Pre-Vaccination and Post-Vaccination Cohorts.
    Lin TL; Fan YH; Chang YL; Ho HJ; Liang LL; Chen YJ; Wu CY
    Front Immunol; 2022; 13():848835. PubMed ID: 35432330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of Varicella During the 2-Dose Varicella Vaccination Program - United States, 2005-2014.
    Lopez AS; Zhang J; Marin M
    MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(34):902-5. PubMed ID: 27584717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of universal vaccination against varicella in Italy.
    Bechini A; Boccalini S; Baldo V; Cocchio S; Castiglia P; Gallo T; Giuffrida S; Locuratolo F; Tafuri S; Martinelli D; Prato R; Amodio E; Vitale F; Bonanni P
    Hum Vaccin Immunother; 2015; 11(1):63-71. PubMed ID: 25483517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of varicella hospitalizations in the United States, 1995-2005.
    Reynolds MA; Watson BM; Plott-Adams KK; Jumaan AO; Galil K; Maupin TJ; Zhang JX; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S120-6. PubMed ID: 18419384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Children with breakthrough varicella infection requiring hospitalization in Turkey (VARICOMP Study 2008-2013).
    Dinleyici EC; Kurugol Z; Kara A; Tezer H; Tas MA; Guler E; Yasa O; Devrim I; Ciftci E; Ozdemir H; Somer A; Ozen M; Sensoy G; Dalgic N; Alhan E;
    Vaccine; 2015 Jul; 33(32):3983-7. PubMed ID: 26133048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the effectiveness of the universal varicella vaccination program in Toscana (Italy), in the period 2010-2013.
    Pieri L; Porchia BR; Pieralli F; Varone O; Niccolai G; Roselli A; Boccalini S; Bonanni P; Bechini A; ;
    Epidemiol Prev; 2015; 39(4 Suppl 1):119-23. PubMed ID: 26499428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Varicella breakthrough infection and effectiveness of 2-dose varicella vaccine in China.
    Pan X; Shu M; Ma R; Fang T; Dong H; Sun Y; Xu G
    Vaccine; 2018 Sep; 36(37):5665-5670. PubMed ID: 30104113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-dose varicella vaccine effectiveness in Brazil: A case-control study.
    Andrade AL; da Silva Vieira MA; Minamisava R; Toscano CM; de Lima Souza MB; Fiaccadori F; Figueiredo CA; Curti SP; Nerger MLBR; Bierrenbach AL;
    Vaccine; 2018 Jan; 36(4):479-483. PubMed ID: 29249544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varicella epidemiology and cost-effectiveness analysis of universal varicella vaccination program in Taiwan.
    Tseng HF; Tan HF; Chang CK
    Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1450-8. PubMed ID: 16610647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Varicella prevention in Costa Rica: impact of a one-dose schedule universal vaccination.
    Avila-Aguero ML; Ulloa-Gutierrez R; Camacho-Badilla K; Soriano-Fallas A; Arroba-Tijerino R; Morice-Trejos A
    Expert Rev Vaccines; 2017 Mar; 16(3):229-234. PubMed ID: 27786560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era.
    Lopez AS; Zhang J; Brown C; Bialek S
    Pediatrics; 2011 Feb; 127(2):238-45. PubMed ID: 21199857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Varicella vaccination in Japan: necessity of implementing a routine vaccination program.
    Ozaki T
    J Infect Chemother; 2013 Apr; 19(2):188-95. PubMed ID: 23483311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy.
    Pozza F; Piovesan C; Russo F; Bella A; Pezzotti P; Emberti Gialloreti L
    Vaccine; 2011 Nov; 29(51):9480-7. PubMed ID: 22015389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of funded varicella immunization programs on varicella-related hospitalizations in IMPACT centers, Canada, 2000-2008.
    Tan B; Bettinger J; McConnell A; Scheifele D; Halperin S; Vaudry W; Law B;
    Pediatr Infect Dis J; 2012 Sep; 31(9):956-63. PubMed ID: 22647896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program.
    Quinn HE; Gidding HF; Marshall HS; Booy R; Elliott EJ; Richmond P; Crawford N; McIntyre PB; Macartney KK;
    J Infect; 2019 Mar; 78(3):220-225. PubMed ID: 30528868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Varicella-related hospitalizations in the vaccine era.
    Ratner AJ
    Pediatr Infect Dis J; 2002 Oct; 21(10):927-31. PubMed ID: 12394814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparing to introduce the varicella vaccine into the Italian immunisation programme: varicella-related hospitalisations in Tuscany, 2004-2012.
    Boccalini S; Bonanni P; Bechini A
    Euro Surveill; 2016 Jun; 21(24):. PubMed ID: 27336188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of ten years of infant universal Varicella vaccination in Sicily, Italy (2003-2012).
    Amodio E; Tramuto F; Cracchiolo M; Sciuto V; De Donno A; Guido M; Rota MC; Gabutti G; Vitale F
    Hum Vaccin Immunother; 2015; 11(1):236-9. PubMed ID: 25483542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe and Complicated Varicella and Associated Genotypes 10 Years After Introduction of a One-Dose Varicella Vaccine Program.
    Marshall HS; Clarke M; Heath C; Quinn H; Richmond PC; Crawford N; Elliott E; Toi C; Kynaston A; Booy R; Macartney K;
    J Infect Dis; 2019 Jan; 219(3):391-399. PubMed ID: 30184182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Varicella vaccination coverage inverse correlation with varicella hospitalizations in Spain.
    Gil-Prieto R; Garcia-Garcia L; San-Martin M; Gil-de-Miguel A
    Vaccine; 2014 Dec; 32(52):7043-6. PubMed ID: 25444825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.